Machine Learning for Biomedicine
ML4BM
![Foto de Machine Learning for Biomedicine](/img/uploaded/38a87e6e48f89cc3b29d34aca3d828e6.jpg)
![Foto de The Bristol-Myers Squibb Children's Hospital](/img/noimage_org.png)
The Bristol-Myers Squibb Children's Hospital
Nuevo Brunswick, Estados UnidosPublicaciones en colaboración con investigadores/as de The Bristol-Myers Squibb Children's Hospital (2)
2024
-
Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1–2, open-label, multicohort trial
The Lancet Oncology, Vol. 25, Núm. 5, pp. 588-602
2019
-
Safety and efficacy of nivolumab monotherapy in recurrent or metastatic cervical, vaginal, or vulvar carcinoma: Results from the phase I/II CheckMate 358 trial
Journal of Clinical Oncology, Vol. 37, Núm. 31, pp. 2825-2834